SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain

The emergence and rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (BA.1.1) has attracted global attention. The numerous mutations in the spike protein suggest that it may have altered susceptibility to immune protection elicited by the existing corona...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianhua, Li, Xiaoyan, Mao, Haiyan, Huang, Chen, Sun, Yi, Miao, Liangbin, Li, Jiaxuan, Song, Wanchen, Zhang, Yanjun, Huang, Jinsong, Chen, Keda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200063/
https://www.ncbi.nlm.nih.gov/pubmed/37178794
http://dx.doi.org/10.1016/j.virusres.2023.199131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200063/
https://www.ncbi.nlm.nih.gov/pubmed/37178794
http://dx.doi.org/10.1016/j.virusres.2023.199131

Ejemplares similares